Nonafact

RSS

human coagulation factor IX

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for Nonafact has been withdrawn at the request of the marketing-authorisation holder.

This EPAR was last updated on 18/02/2020

Authorisation details

Product details
Name
Nonafact
Agency product number
EMEA/H/C/000348
Active substance
human coagulation factor IX
International non-proprietary name (INN) or common name
human coagulation factor IX
Therapeutic area (MeSH)
Hemophilia B
Anatomical therapeutic chemical (ATC) code
B02BD04
Publication details
Marketing-authorisation holder
Sanquin Plasma Products B.V.
Revision
9
Date of issue of marketing authorisation valid throughout the European Union
03/07/2001
Contact address
Plesmanlaan 125
NL-1066 CX Amsterdam
The Netherlands

Product information

24/11/2016 Nonafact - EMEA/H/C/000348 - IB/0062

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Antihemorrhagics

Therapeutic indication

Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor IX deficiency).

Assessment history

How useful was this page?

Add your rating